Andrzej Klein
Impact in
-
- Dialysis and Renal Disease Management
Papers in
-
- PI3K/AKT/mTOR signaling in cancer 4
- Glycosylation and Glycoproteins Research 4
- Protein Hydrolysis and Bioactive Peptides 2
- Co-authors
- Aleksandra Jurek (3 shared papers)Przemysław Holko (2 shared papers)Agnieszka Cierniak (2 shared papers)Francesca Larese Filon (2 shared papers)Julia Borowczyk (2 shared papers)T Cichocki (3 shared papers)Matteo Crosera (2 shared papers)Justyna Drukała (2 shared papers)
- Journals
- Clinical Biochemistry (2 papers)Journal of Chromatography A (2 papers)Clinica Chimica Acta (2 papers)Biological Chemistry (1 paper)European Journal of Pharmaceutics and Biopharmaceutics (1 paper)
- Partner nations
- PolandVietnamUnited States
In The Last Decade
Andrzej Klein
31 papers receiving 370 citations
Peers
Comparison fields: 5 of 87
- Clinical Biochemistry 33
- Nephrology 34
- Inorganic Chemistry 56
- Biomaterials 37
- Biochemistry 20
Countries citing papers authored by Andrzej Klein
This map shows the geographic impact of Andrzej Klein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrzej Klein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrzej Klein more than expected).
Fields of papers citing papers by Andrzej Klein
This network shows the impact of papers produced by Andrzej Klein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrzej Klein. The network helps show where Andrzej Klein may publish in the future.
Co-authors
The 25 scholars most cited alongside Andrzej Klein, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 31 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 60 | |
| 2 | 2012 | 45 | |
| 3 | 2005 | 35 | |
| 4 | 2008 | 31 | |
| 5 | 1976 | 25 | |
| 6 | The effect of vanadyl sulphate (VOSO4) on autocrine growth of human epithelial cancer cell lines. | 2008 | 19 |
| 7 | 2008 | 17 | |
| 8 | Comparison of the effect of VOSO4, Na3VO4 and NaVO3 on proliferation, viability and morphology of H35-19 rat hepatoma cell line. | 2007 | 16 |
| 9 | 2008 | 14 | |
| 10 | 1974 | 14 | |
| 11 | 1985 | 13 | |
| 12 | 2012 | 12 | |
| 13 | 2011 | 12 | |
| 14 | 2011 | 9 | |
| 15 | 1978 | 8 | |
| 16 | 1970 | 8 | |
| 17 | 2012 | 7 | |
| 18 | 2004 | 7 | |
| 19 | 1981 | 5 | |
| 20 | 1978 | 5 |
About Andrzej Klein
Andrzej Klein is a scholar working on Molecular Biology, Endocrinology, Diabetes and Metabolism, Oncology, Clinical Biochemistry and Biochemistry, having authored 31 papers that have together received 387 indexed citations. Recurring topics across this work include HER2/EGFR in Cancer Research (4 papers), PI3K/AKT/mTOR signaling in cancer (4 papers), Glycosylation and Glycoproteins Research (4 papers), Vanadium and Halogenation Chemistry (3 papers), Biochemical Acid Research Studies (3 papers), Food Quality and Safety Studies (2 papers), Protein Hydrolysis and Bioactive Peptides (2 papers) and Metal-Catalyzed Oxygenation Mechanisms (2 papers). The work is most often cited by research in Clinical Biochemistry (33 citations), Nephrology (34 citations), Inorganic Chemistry (56 citations), Biomaterials (37 citations) and Biochemistry (20 citations). Andrzej Klein has collaborated with scholars based in Poland, Vietnam and United States. Frequent co-authors include Aleksandra Jurek, Przemysław Holko, Agnieszka Cierniak, Francesca Larese Filon, Julia Borowczyk, T Cichocki, Matteo Crosera, Justyna Drukała, Jolanta Jura and Łukasz Skalniak. Their work appears in journals such as Clinical Biochemistry, Journal of Chromatography A, Clinica Chimica Acta, Biological Chemistry and European Journal of Pharmaceutics and Biopharmaceutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.